Search - tctmd.com

Displaying 141 - 160 of 223

Sort: Relevancy | Date

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Daily News

No ACS? Noninvasive Follow-up Not Helpful in Most Chest-Pain Patients

Shelley Wood

October 06, 2020

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Conference News ESC 2020

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Shelley Wood

September 04, 2020

News Daily News

Operator, Hospital Experience Matter for CTO PCI Success

Todd Neale

August 26, 2020

News Daily News

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

Yael L. Maxwell

August 20, 2020

News Daily News

Malnutrition Linked to Mortality, MACE in ACS Patients

Yael L. Maxwell

August 11, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Daily News

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Michael O'Riordan

June 01, 2020

News Conference News CRT 2020

Operator Volume Matters in Left Main PCI: BCIS Analysis

Michael O'Riordan

March 05, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

Advertisement

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

No ACS? Noninvasive Follow-up Not Helpful in Most Chest-Pain Patients

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Operator, Hospital Experience Matter for CTO PCI Success

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

Malnutrition Linked to Mortality, MACE in ACS Patients

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

TCTMD’s Top 10 Most Popular Stories for July 2020

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

July 2020 News Roundup

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Operator Volume Matters in Left Main PCI: BCIS Analysis

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content